Picture of Avadel Pharmaceuticals logo

AVDL Avadel Pharmaceuticals Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Avadel Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments64.222315796.5105
Net Total Accounts Receivable
Net Total Receivables12.439.131.82.5913.4
Total Inventory
Prepaid Expenses
Total Current Assets82.4263192101134
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment4.162.962.942.553.18
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets151312247133165
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities3615.12155.836.9
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities18114916915477
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity-29.216278.2-21.187.7
Total Liabilities & Shareholders' Equity151312247133165
Total Common Shares Outstanding
Total Preferred Shares Outstanding